Brett Knoblauch price targets & ratings
Brett Knoblauch is a Wall Street equity research analyst at Cantor, covering CoreWeave. Price Target holds 7 of these research notes since August 2026, each reproduced verbatim. Latest: Cantor Fitzgerald Lowers CoreWeave Price Target to $100 (Nov 11, 2026).
Career
Firms Brett Knoblauch has published research under, with the period and number of notes Price Target holds for each.
- CantorAugust 2026 – present notes on Price Target7 notes
Current calls
Latest rating and price target on each company, with the implied move from the last share price.
- AI 1CoreWeave
| Buy | $100 | +153% | Nov 11, 2026 | 7 |
Notes by Brett Knoblauch 7
CoreWeaveOverweightCantor · Cut price target −43%, kept ratingCut target · Nov 11
$100from $176−43%
CoreWeaveOverweightCantor · Kept rating and price targetReiterated · Oct 26
$176maintained
CoreWeaveOverweightCantor · Kept rating and price targetReiterated · Oct 19
$176maintained
CoreWeaveOverweightCantor · Kept rating and price targetReiterated · Oct 16
$176maintained
CoreWeaveOverweightCantor · Kept rating and price targetReiterated · Oct 2
$176maintained
CoreWeaveOverweightCantor · Kept rating and price targetReiterated · Sep 28
$176maintained
CoreWeaveOverweightCantor · Raised price target +7%, kept ratingRaised target · Aug 12
$178from $167+7%
Questions about Brett Knoblauch
Who is Brett Knoblauch?
Brett Knoblauch is an equity research analyst at Cantor, covering CoreWeave. Price Target holds 7 research notes by Brett Knoblauch, the earliest from August 2026.
Which stocks does Brett Knoblauch cover?
In the notes Price Target holds, Brett Knoblauch covers 1 company: CoreWeave.
How accurate are Brett Knoblauch’s price targets?
Price targets are 12-month calls, so Price Target scores each one once it is a year old. Brett Knoblauch has no targets that old in our archive yet, so there is no rate to show. How we score
What is Brett Knoblauch’s latest price target?
The most recent price target from Brett Knoblauch in our archive is $100 on CoreWeave, with a Buy rating, published November 11, 2026. Read the note
All Wall Street analysts · All Cantor notes · Most accurate firms